| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 0 | 17.605 | 29.375 | 28.839 | 30.454 | 26.210 |
| Total Income - EUR | - | - | - | - | 0 | 17.605 | 29.375 | 28.839 | 30.454 | 26.210 |
| Total Expenses - EUR | - | - | - | - | 116 | 627 | 977 | 1.783 | 8.832 | 9.494 |
| Gross Profit/Loss - EUR | - | - | - | - | -116 | 16.978 | 28.398 | 27.056 | 21.622 | 16.716 |
| Net Profit/Loss - EUR | - | - | - | - | -116 | 16.484 | 27.534 | 26.353 | 21.363 | 13.978 |
| Employees | - | - | - | - | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - David Anestezia S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 21 | 536 | 1.183 | 534 | 133 | 1.572 |
| Current Assets | - | - | - | - | 42 | 16.178 | 26.771 | 51.566 | 28.612 | 20.891 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 237 |
| Receivables | - | - | - | - | 0 | 2.148 | 23.152 | 22.185 | 4.023 | 11.747 |
| Cash | - | - | - | - | 42 | 14.029 | 3.619 | 29.382 | 24.589 | 8.906 |
| Shareholders Funds | - | - | - | - | -74 | 16.411 | 27.582 | 26.402 | 27.846 | 14.026 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 137 | 303 | 371 | 25.699 | 899 | 9.254 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - David Anestezia S.r.l.